PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Université de Paris, Infection Antimicrobials Modelling Evolution (IAME), Institut National de la Santé et de la Recherche Médicale (INSERM), Paris, France.\', \'Assistance Publique - Hôpitaux de Paris (AP-HP), University Hospital Bichat-Claude Bernard, Laboratoire de Virologie, Paris, France.\', \'Assistance Publique - Hôpitaux de Paris (AP-HP), University Hospital Bichat-Claude Bernard, Maladies Infectieuses et Tropicales, Paris, France.\', \'Assistance Publique - Hôpitaux de Paris (AP-HP), University Hospital Bichat-Claude Bernard, Réanimation Médicale et Infectieuses, Paris, France.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3389/fcimb.2021.792202
?:doi
?:hasPublicationType
?:journal
  • Frontiers in cellular and infection microbiology
is ?:pmid of
?:pmid
?:pmid
  • 34976868
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.703
?:rankingScore_hIndex
  • 43
?:title
  • Earlier In Vitro Viral Production With SARS-CoV-2 Alpha Than With Beta, Gamma, B, or A.27 Variants.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all